Mobile

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfu...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-013616-12

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to determine the efficacy of dapoxetine (30/60 mg prn) compared with placebo after 12 weeks of treatment in prolonging IELT (intravaginal ejaculatory latency time) in men with PE (premature ejaculation) and ED (erectile dysfunction) who are currently being treated with a PDE-5 inhibitor (ie, sildenafil, vardenafil, or tadalafil) for ED.

Critère d'inclusion

  • premature ejaculation

Liens